Thanks Flight,
Still many many risks, but new management are progressing well, their clinical trials showed statistically significant improvements to diagnosed patients.
PRR's process prolongs life to those affected.
Dendreon in the US has raised eyebrows and CSL's NPAT was strong.
Cheers,
The Sparkler
- Forums
- ASX - By Stock
- us fda preind meeting request submitted for cv
Thanks Flight,Still many many risks, but new management are...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 57289 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 52306 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 57289 | 0.330 |
5 | 29051 | 0.325 |
7 | 113477 | 0.320 |
1 | 55000 | 0.315 |
3 | 48550 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 52306 | 3 |
0.345 | 73155 | 7 |
0.350 | 100659 | 8 |
0.355 | 147500 | 3 |
0.360 | 123645 | 5 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |